Immune Thrombocytopenia classification: Difference between revisions
mNo edit summary |
overview completed |
||
(One intermediate revision by the same user not shown) | |||
Line 8: | Line 8: | ||
OR | OR | ||
Immune thrombocytopenia may be classified according to associated conditions into groups: primary or secondary. | |||
OR | OR | ||
Line 17: | Line 17: | ||
OR | OR | ||
Based on the duration of symptoms, | Based on the duration of symptoms,Immune thrombocytopenia may be classified as either acute, persistent and chronic. | ||
OR | OR | ||
Line 43: | Line 43: | ||
Immune Thrombocytopenia may be classified into two subtypes based on associated disease: | Immune Thrombocytopenia may be classified into two subtypes based on associated disease: | ||
*Primary ( | *Primary ( isolated thrombocytopenia < 100 <math>\times</math><math>10^{9}</math>/L in the absence of co-existing disorder) | ||
*[[Secondary]] ( associated to another disease such as ITP associated with [[common variable immune deficiency]] (CVID). <ref name="pmidhttps://doi.org/10.1016/j.autrev.2014.01.0262">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=https://doi.org/10.1016/j.autrev.2014.01.026 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }}</ref> | *[[Secondary]] ( associated to another disease such as ITP associated with [[common variable immune deficiency]] (CVID). <ref name="pmidhttps://doi.org/10.1016/j.autrev.2014.01.0262">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=https://doi.org/10.1016/j.autrev.2014.01.026 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }}</ref> | ||
Latest revision as of 18:49, 4 February 2021
Immune Thrombocytopenia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Immune Thrombocytopenia classification On the Web |
American Roentgen Ray Society Images of Immune Thrombocytopenia classification |
Risk calculators and risk factors for Immune Thrombocytopenia classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maryam Barkhordarian, M.D.[2]
Overview
There is no established system for the classification of [disease name].
OR
Immune thrombocytopenia may be classified according to associated conditions into groups: primary or secondary.
OR
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3]. [Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
OR
Based on the duration of symptoms,Immune thrombocytopenia may be classified as either acute, persistent and chronic.
OR
If the staging system involves specific and characteristic findings and features: According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
The staging of [malignancy name] is based on the [staging system].
OR
There is no established system for the staging of [malignancy name].
Classification
Immune thrombocytopenia may be classified according to disease phase into three groups:
- Newly diagnosed ITP (0-3 months)
- Persistent ITP (3-12 moths)
- Chronic ITP ( > 12 months)
Immune Thrombocytopenia may be classified into two subtypes based on associated disease:
- Primary ( isolated thrombocytopenia < 100 <math>\times</math><math>10^{9}</math>/L in the absence of co-existing disorder)
- Secondary ( associated to another disease such as ITP associated with common variable immune deficiency (CVID). [1]
References
- ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes" Check
|url=
value (help). Biochem Pharmacol. 24 (17): 1639–41. PMID https://doi.org/10.1016/j.autrev.2014.01.026 Check|pmid=
value (help).